3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 4
1
Status
Completed
5
Recruiting
3
Unknown
2
Not yet recruiting
2
Withdrawn
1
Terminated
1
Active not recruiting
1
Sponsor Class
OTHER
2
INDUSTRY
1
Study Type
Observational
5
Interventional
3
Sponsor
Cancer Type
Endocrine
2
CNS
2
NET
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Brain Neoplasms
2
Prostatic Neoplasms
1
Pituitary Neoplasms
1
Neuroendocrine Tumors
1
Meningioma
1
Glioma
1
Fatigue
1
Colorectal Neoplasms
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
pembrolizumab
555
Specimen Handling
459
Carboplatin
446
Magnetic Resonance Spectroscopy
427
Cyclophosphamide
412
Cisplatin
404
Gemcitabine
314
Radiotherapy
313
Bevacizumab
310
Paclitaxel
300
Biopsy
260
Drug Therapy
252
Capecitabine
241
Oxaliplatin
240
fludarabine
236
Nivolumab
226
venetoclax
225
Injections
214
Docetaxel
203
Fluorouracil
201
Dexamethasone
186
Radiosurgery
172
Rituximab
161
Pemetrexed
157
durvalumab
144
Standard of Care
143
atezolizumab
139
toripalimab
137
tislelizumab
137
Leucovorin
137
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Recruiting
×
Interventional
×
Neuropsychological Tests
×
Clear all
NCT04373564
2026-01-22
ODYSSEY
Guerbet
Phase 4
Recruiting
2,076 enrolled
NCT05340881
2025-09-18
SLEPBT
Baylor College of Medicine
Phase NA
Recruiting
40 enrolled
NCT05727605
2024-05-08
NARCiS
Universitaire Ziekenhuizen KU Leuven
Phase NA
Recruiting
120 enrolled